Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients

Among the potential hazards of HDM immunotherapy (AIT) with HDM allergenic extracts is the possible initiation of de novosensitizations caused by a lack of complementarity between a given HDM vaccine’s content and a patient’s molecular sensitization profile. To investigate whether immunotherapy with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nittner-Marszalska, Marita, Kopeć, Agnieszka, Foks-Ciekalska, Aleksandra, Lata, Aleksandra, Bogacz- Piaseczyńska, Agnieszka, Rosiek-Biegus, Marta, Zajac, Magdalena, Bożek, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762793/
https://www.ncbi.nlm.nih.gov/pubmed/36444880
http://dx.doi.org/10.1080/21645515.2022.2148815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762793/
https://www.ncbi.nlm.nih.gov/pubmed/36444880
http://dx.doi.org/10.1080/21645515.2022.2148815

Ejemplares similares